文献速递妇科

复发性卵巢癌脾门孤立转移的腹腔镜脾切除术

Laparoscopic splenectomy for secondary cytoreduction of ovarian cancer in a woman with localized splenic recurrence.
PubMed 文献 · Gynecol Oncol · 2020-01-16

本文通过手术视频展示一例47岁铂敏感高级别浆液性卵巢癌患者,脾门1.5×1.0 cm孤立复发灶行腹腔镜二次减瘤联合脾切除术的逐步手术方法,强调患者选择、体位、脾韧带离断顺序及脾动静脉处理,并报告围手术期与肿瘤学结局。

要点

  • 腹腔镜脾切除术适用于严格选择的孤立脾转移复发性卵巢癌患者。
  • 脾门病变需按特定顺序离断脾韧带并处理脾动静脉。
  • 患者选择、体位与精细手术技术是手术可行安全的关键。

核心结论

  • 在适当患者选择、体位及精细手术技术下,腹腔镜脾切除术用于复发性卵巢癌孤立脾转移是可行且安全的。

研究设计与样本

  • 视频展示单例47岁铂敏感高级别浆液性卵巢癌患者,脾门1.5×1.0 cm孤立复发灶,行腹腔镜二次减瘤联合脾切除术。

主要发现

  • 手术估计失血量100 cc,手术时间3 h。
  • 化疗后无病间期及无疾病证据状态达14个月。

关键数值与推荐

  • 二次减瘤手术适应证、微创手术合适候选者、患者体位原则及左上腹解剖在视频中回顾。
  • 脾门病变中脾韧带按特定顺序离断,并分离结扎脾动脉和脾静脉。

临床怎么用

  • 对严格选择的孤立脾转移复发性卵巢癌患者,可考虑腹腔镜脾切除术作为二次减瘤选项。

局限性

  • 证据来自单例手术视频展示,非对照研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Laparoscopic splenectomy is a potential surgical option for the treatment of isolated gynecologic cancer recurrence to the spleen [1-7]. The purpose of this video is to demonstrate a step-by-step approach for laparoscopic splenectomy in the setting of recurrent, oligometastatic ovarian cancer. METHODS: We present the case of a 47-year-old female with recurrent, platinum-sensitive high-grade serous ovarian cancer. A computer tomographic scan demonstrated an isolated 1.5 × 1.0 cm recurrence in the splenic hilum. A laparoscopic secondary cytoreduction with splenectomy was planned. The surgical procedure was recorded via the video camera tower, and the key steps for a laparoscopic splenectomy were identified and highlighted. RESULTS: The indications for secondary cytoreductive surgery, the appropriate candidates for minimally invasive surgery, patient positioning principles to set the surgeon up for success, and left upper quadrant anatomy are reviewed. In the surgical case and in the setting of hilar disease, the technique and rationale for ligating the major splenic ligaments in a particular order are reviewed. The procedure for isolating and ligating the dominant vascular structures - the splenic artery and vein - are reviewed. Finally, perioperative and oncologic outcomes, including an estimated blood loss of 100 cc, operative time of 3 h, a disease-free interval and "no evidence of disease" status after chemotherapy at 14 months, are emphasized. CONCLUSIONS: In this video, both anatomical references and the surgical technique for a laparoscopic splenectomy in the setting of recurrent ovarian cancer are illustrated. We demonstrate that laparoscopic splenectomy is feasible and safe with proper patient selection and positioning as well as meticulous surgical technique.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Acosta-Torres S, Fader AN. Laparoscopic splenectomy for secondary cytoreduction of ovarian cancer in a woman with localized splenic recurrence. Gynecol Oncol. 2020. PMID: 31955860. doi:10.1016/j.ygyno.2019.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。